04:39 AM EST, 01/26/2026 (MT Newswires) -- Merck ( MRK ) has dropped its bid to acquire Revolutions Medicines (RVMD) over a disagreement on price, The Wall Street Journal reported over the weekend, citing unnamed people familiar with the matter.

Merck & Co ( MRK ) has dropped its bid to acquire Revolutions Medicines (RVMD) over a disagreement on price, The Wall Street Journal reported over the weekend, citing people familiar with the matter.

Media outlets reported earlier in January that Merck ( MRK ) was in advanced talks on a potential deal that could have valued the oncology company at around $30 billion.

Takeover talks could still resume or another potential buyer could emerge, according to the report.

Revolution Medicines ( RVMD ) shares were 24% lower in premarket activity.

Merck ( MRK ) and Revolutions Medicines did not immediately reply to MT Newswires' requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)